S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Innoviva (INVA) Earnings Date, Estimates & Call Transcripts

$14.48
+0.01 (+0.07%)
(As of 04/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Feb. 29)
$0.76 Beat By $0.76
Skip Charts & View Estimated and Actual Earnings Data

INVA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INVA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

INVA Earnings Date and Information

Innoviva last announced its quarterly earnings results on February 29th, 2024. The biotechnology company reported $0.76 earnings per share for the quarter. The company had revenue of $85.84 million for the quarter. Innoviva has generated $2.18 earnings per share over the last year ($2.18 diluted earnings per share) and currently has a price-to-earnings ratio of 6.6. Innoviva has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Innoviva Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
2/29/2024Q4 2023-$0.76+$0.76$0.76-$85.84 million
11/1/2023Q3 2023-$0.98+$0.98$0.98-$67.26 million
8/2/2023Q2 2023-$0.08+$0.08$0.14-$80.99 million
5/9/2023Q1 2023-$0.42+$0.42$0.42$68.04 million$76.37 million
2/28/2023Q4 2022$0.41$0.25($0.16)$1.48$98.31 million$65.80 million
11/9/2022Q3 2022$2.75$0.60($2.15)($1.60)$361.45 million$67.26 million
7/27/2022Q2 2022$0.55$0.05($0.50)$0.05$103.42 million$108.22 million
4/27/2022Q1 2022$0.40$0.42+$0.02$0.64$51.13 million$90.06 million
2/9/2022Q4 2021$0.41$0.55+$0.14$0.96-$107.68 million
10/27/2021Q3 2021$0.43$0.90+$0.47$0.90-$97.86 million
7/28/2021Q2 2021$0.29$0.90+$0.61$0.90-$100.81 million
4/28/2021Q1 2021($0.01)$0.84+$0.85$0.84-$85.52 million

Innoviva Earnings - Frequently Asked Questions

When is Innoviva's earnings date?

Innoviva has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on INVA's earnings history.

How much revenue does Innoviva generate each year?

Innoviva (NASDAQ:INVA) has a recorded annual revenue of $310.46 million.

How much profit does Innoviva generate each year?

Innoviva (NASDAQ:INVA) has a recorded net income of $179.72 million. INVA has generated $2.18 earnings per share over the last four quarters.

What is Innoviva's price-to-earnings ratio?

Innoviva (NASDAQ:INVA) has a trailing price-to-earnings ratio of 6.64.


More Earnings Resources from MarketBeat

This page (NASDAQ:INVA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners